# Yongjin Group

> Yongjin Group is a VC fund in Shanghai backing Health Care, EdTech and Education. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 9
- Last investment: Sep 2022
- Lead investor: 22%
- Last updated: Aug 2026
- Website: http://www.yongjin.com.cn/en/

Yongjin Group is a holding group company focusing on the financial service, private equity investment and medical industry. Their mission is to create “the most reliable financial service institution in the capital market”. Yongjin Group has achieved significant business performance based on the management philosophy, “combining a professional teamwith a strategy of accurate decision making”.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 44% |
| EdTech | 2 | 22% |
| Education | 2 | 22% |
| E-Learning | 2 | 22% |
| Biotechnology | 2 | 22% |

19 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 44% |
| Series B | 2 | 22% |
| Angel | 1 | 11% |
| Series C | 1 | 11% |
| Funding Round | 1 | 11% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 4 | 44% |
| Israel | 2 | 22% |
| United States | 2 | 22% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Optten | Optten is a comprehensive energy technology solutions provider, committed to becoming a technology, equipment and service provider |  | Series A | Sep 05, 2022 |  |
| ITabMed | ITabMed is a clinical-stage biotech company located in Shanghai, China. The company was founded in 2020 and is registered in Lin Gang Sci-Tech City, Shanghai. It was a spin-off entity from the former “Generon BioMed Ltd.”. The company is focused on immunotherapy drug research and development to treat cancer. | $20M | Series A | Dec 01, 2021 |  |
| TechsoMed | TechsoMed is an Israeli based medical device company, developing ultrasound based real-time monitoring systems for thermal ablation procedures. The applications of thermal ablation are numerous: tumor destruction, heart arrhythmia, blood pressure treatments and more. The procedure has market size in the billions, but lacks real-time monitoringcapabilities, causing high failure rates.Their technology offers added value to patients, physicians and insurance companies by solving the high failure rate of these minimally invasive and cost effective procedures. | $7M | Series B | Mar 03, 2021 |  |
| Minerva Project | Minerva Project is an educational innovator, providing higher education offerings to the Minerva Schools at KGI, as well as other educational partners. Building upon the traditions of liberal arts and sciences education, Minerva is committed to preparing global leaders and innovators for the complexities of the 21st century. By integratingpedagogy, curriculum, and the class environment in its innovative educational system, Minerva enables institutions of all types and sizes to improve learning outcomes for students around the world.Minerva Project was founded in 2011 and is headquartered in San Francisco, California. | $57M | Series C | Jul 11, 2019 |  |
| Kingdee Healthcare | Kingdee Healthcare provides hospital information platform, mobile healthcare platform, online hospital appointment booking services, and hospital resource planning. It currently has over eight millions users, and has provided services for over 3,000 hospitals and healthcare institutions, the firm claims. | $14M | Series A | Mar 27, 2017 |  |
| Rainbow Medical | Rainbow Medical is a unique private operational company that seeds and grows companies developing breakthrough medical devices invented by Yossi Gross in a diverse range of medical fields. By addressing significant unmet market needs, Rainbow Medical seeks to generate exceptional returns for its investors. | $25M |  | Feb 16, 2015 |  |
| Minerva Project | Minerva Project is an educational innovator, providing higher education offerings to the Minerva Schools at KGI, as well as other educational partners. Building upon the traditions of liberal arts and sciences education, Minerva is committed to preparing global leaders and innovators for the complexities of the 21st century. By integratingpedagogy, curriculum, and the class environment in its innovative educational system, Minerva enables institutions of all types and sizes to improve learning outcomes for students around the world.Minerva Project was founded in 2011 and is headquartered in San Francisco, California. | $45M | Series B | Oct 15, 2014 |  |
| Ready4 | Since 2012, Ready4 (formerly known as LTG Exam Prep Platform) has been on a mission to create the world’s most advanced mobile learning platform and connect students to opportunity. Today, with over 1 million downloads across 195+ countries they are transforming the way students prepare for standardized exams. To-date they have launched: Ready4GMAT, Ready4 GRE, Ready4 SAT, Ready4 ACT, Ready4 PSAT, Ready4 MCAT, and U-Match across both iOS and Android platforms. In addition to readying their students for major exams, they provide students with school research, application planning, and scholarship tools all within their mobile apps. Universities, in turn, can partner with Ready4 to connect with students worldwide. |  | Series A | Aug 01, 2014 |  |
| UPYUN | UPYUN is a cloud CDN services provider. |  | Angel | Jan 13, 2013 |  |

9 of 9 investments shown.

## Co-investors
- [TAL Education Group](https://shizune.co/investors/profile/tal) — VC Fund, 3 deals together
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund, 2 deals together
- [3E Bioventures](https://shizune.co/investors/profile/3e-bioventures) — VC Fund, 1 deal together
- [Ameba Capital](https://shizune.co/investors/profile/ameba-capital) — VC Fund, 1 deal together
- [Atlas Venture](https://shizune.co/investors/profile/atlas-venture) — VC Fund, 1 deal together
- [Axil Capital](https://shizune.co/investors/profile/axil-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Yongjin Group invest in?

Yongjin Group invests primarily in Health Care, EdTech and Education startups, most often at Series A and Series B stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Yongjin Group last invest?

The most recent investment recorded for Yongjin Group closed in Sep 2022. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co